The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain.

The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot made by Pfizer, alerting patients to a possible risk for a type of brain ...

The U.S. Food and Drug Administration (FDA) has updated the warning label for the Depo-Provera birth control shot to include information about the risk of meningioma brain tumors. The label update is ...

Depo Provera: The Food and Drug Administration approved a label change on Friday for Pfizer’s birth control injection, Depo-Provera, alerting patients to the risk of meningioma, a tumor that develops ...

The FDA has approved a label change on the long-acting injectable contraceptive depot medroxyprogesterone acetate, commonly known as Depo-Provera, to warn users of a potential risk of meningioma. The ...

Depo-Provera, a widely used birth control shot, has been praised for its convenience and affordability. But mounting research and alarming personal stories reveal a darker side to the shot — serious ...

WASHINGTON (7News) — Millions of women in the United States trust the safety of their birth control, never imagining it could lead to severe health conditions like a brain tumor. Yet, cases across the ...

The Depo-Provera birth control shot has been linked to an increased risk of a type of brain tumors known as meningiomas. Women who received the Depo shot and were diagnosed with meningioma brain ...

Ellen Relkin, who filed the first case on Tuesday, predicts thousands of lawsuits after a French study in March found the contraceptive Depo-Provera had a 550% higher chance of developing brain tumors ...